Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging

Chronic obstructive pulmonary disease (COPD) has been recently characterized as a disease of accelerated lung aging, but the mechanism remains unclear. Tetraspanins have emerged as key players in malignancy and inflammatory diseases. Here, we found that CD9/CD81 double knockout (DKO) mice with a COPD-like phenotype progressively developed a syndrome resembling human aging, including cataracts, hair loss, and atrophy of various organs, including thymus, muscle, and testis, resulting in shorter survival than wild-type (WT) mice. Consistent with this, DNA microarray analysis of DKO mouse lungs revealed differential expression of genes involved in cell death, inflammation, and the sirtuin-1 (SIRT1) pathway. Accordingly, expression of SIRT1 was reduced in DKO mouse lungs. Importantly, siRNA knockdown of CD9 and CD81 in lung epithelial cells additively decreased SIRT1 and Foxo3a expression, but reciprocally upregulated the expression of p21 and p53, leading to reduced cell proliferation and elevated apoptosis. Furthermore, deletion of these tetraspanins increased the expression of pro-inflammatory genes and IL-8. Hence, CD9 and CD81 might coordinately prevent senescence and inflammation, partly by maintaining SIRT1 expression. Altogether, CD9/CD81 DKO mice represent a novel model for both COPD and accelerated senescence.

[1]  O. Burghuber,et al.  BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study , 2009, Respiratory research.

[2]  P. Barnes,et al.  COPD as a disease of accelerated lung aging(a). , 2009, Revista portuguesa de pneumologia.

[3]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[4]  C. Boucheix,et al.  Tetraspanins at a glance , 2014, Journal of Cell Science.

[5]  J. Campisi Aging, cellular senescence, and cancer. , 2013, Annual review of physiology.

[6]  H. Saya,et al.  Statins Decrease Lung Inflammation in Mice by Upregulating Tetraspanin CD9 in Macrophages , 2013, PloS one.

[7]  W. Cullen,et al.  Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.

[8]  A. Itai,et al.  New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet. , 2005, Current drug discovery technologies.

[9]  Hongwei Yao,et al.  SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. , 2012, The Journal of clinical investigation.

[10]  R Weinberg,et al.  New Concepts... , 1995 .

[11]  O. Dorchies,et al.  Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea , 2012, Histochemistry and Cell Biology.

[12]  Cellular senescence and cancer , 1999, The Journal of pathology.

[13]  L. Guarente,et al.  SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[14]  K. Takeda,et al.  Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. , 2012, American journal of respiratory and critical care medicine.

[15]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[16]  L. Guarente Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. , 2011, The New England journal of medicine.

[17]  F. Berditchevski,et al.  Tetraspanins in human epithelial malignancies , 2011, The Journal of pathology.

[18]  E. Mekada,et al.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes , 2003, The Journal of cell biology.

[19]  I. Rahman,et al.  Redox regulation of SIRT1 in inflammation and cellular senescence. , 2013, Free radical biology & medicine.

[20]  T. Funahashi,et al.  Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. , 2011, American journal of respiratory and critical care medicine.

[21]  Ron O. Dror,et al.  Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket , 2016, Cell.

[22]  J. Haigh Role of VEGF in organogenesis , 2008, Organogenesis.

[23]  Alan D. Lopez THE GLOBAL BURDEN OF DISEASE 1990-2020 , 2001 .

[24]  A. Anzueto,et al.  Impact of statins and ACE inhibitors on mortality after COPD exacerbations , 2009, Respiratory research.

[25]  T. Tsuji,et al.  Alveolar cell senescence in patients with pulmonary emphysema. , 2006, American journal of respiratory and critical care medicine.

[26]  M. Hemler Tetraspanin proteins promote multiple cancer stages , 2013, Nature Reviews Cancer.

[27]  Mustafa Saad,et al.  Implications for Therapy , 2016 .

[28]  I. Rahman,et al.  SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[29]  K. Campbell,et al.  Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81 , 1997, The EMBO journal.

[30]  Kenji Mizuguchi,et al.  An integrative data analysis platform for gene set analysis and knowledge discovery in a data warehouse framework , 2016, Database J. Biol. Databases Curation.

[31]  I. Tachibana,et al.  Preventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory cell and molecular biology.

[32]  Masahiro Sato,et al.  CD81 and CD9 work independently as extracellular components upon fusion of sperm and oocyte , 2012, Biology Open.

[33]  Matt Kaeberlein,et al.  Absence of effects of Sir2 over-expression on lifespan in C. elegans and Drosophila , 2011, Nature.

[34]  J. Sznajder,et al.  Pulmonary Perspective , 2012 .

[35]  P. Barnes Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs , 2010, PLoS medicine.

[36]  A. Salminen,et al.  Crosstalk between Oxidative Stress and SIRT1: Impact on the Aging Process , 2013, International journal of molecular sciences.

[37]  K. Maruyama,et al.  Deletion of Tetraspanin CD9 Diminishes Lymphangiogenesis in Vivo and in Vitro* , 2012, The Journal of Biological Chemistry.

[38]  A. Polesskaya,et al.  Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81 , 2013, Nature Communications.

[39]  E. Mekada,et al.  Double Deficiency of Tetraspanins CD9 and CD81 Alters Cell Motility and Protease Production of Macrophages and Causes Chronic Obstructive Pulmonary Disease-like Phenotype in Mice* , 2008, Journal of Biological Chemistry.

[40]  K. Rabe,et al.  From COPD to chronic systemic inflammatory syndrome? , 2007, The Lancet.

[41]  Keiichi Higuchi,et al.  A new murine model of accelerated senescence , 1981, Mechanisms of Ageing and Development.

[42]  M. Hemler Tetraspanin functions and associated microdomains , 2005, Nature Reviews Molecular Cell Biology.

[43]  K. Kostikas,et al.  Can we delay the accelerated lung aging in COPD? Anti-aging molecules and interventions. , 2013, Current drug targets.

[44]  David A Sinclair,et al.  The intersection between aging and cardiovascular disease. , 2012, Circulation research.

[45]  Y. Fukuchi The aging lung and chronic obstructive pulmonary disease: similarity and difference. , 2009, Proceedings of the American Thoracic Society.

[46]  Tadashi Kaname,et al.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing , 1997, Nature.

[47]  P. Barnes,et al.  Accelerated ageing of the lung in COPD: new concepts , 2015, Thorax.

[48]  Animesh Nandi,et al.  Suppression of Aging in Mice by the Hormone Klotho , 2005, Science.

[49]  N. Chavannes,et al.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. , 2002, American journal of respiratory and critical care medicine.

[50]  W. Thurlbeck,et al.  Postnatal growth of the mouse lung. , 1975, Journal of anatomy.

[51]  A. Ishigami,et al.  Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[53]  J. Hoeijmakers,et al.  Aging and Genome Maintenance: Lessons from the Mouse? , 2003, Science.

[54]  M. Sanaa,et al.  Surface antigen expression in spleen cells of C57Bl/6 mice during ageing: influence of sex and parity , 1997, Clinical and experimental immunology.

[55]  F. Mulero,et al.  A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging , 2009, Nature Genetics.

[56]  M. Hemler Targeting of tetraspanin proteins — potential benefits and strategies , 2008, Nature Reviews Drug Discovery.

[57]  M. Decramer,et al.  Chronic obstructive pulmonary disease and comorbidities. , 2013, The Lancet. Respiratory medicine.

[58]  P. Elliott,et al.  Sirtuins — novel therapeutic targets to treat age-associated diseases , 2008, Nature Reviews Drug Discovery.

[59]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[60]  K. Kuwano,et al.  Autophagy Induction by SIRT6 through Attenuation of Insulin-like Growth Factor Signaling Is Involved in the Regulation of Human Bronchial Epithelial Cell Senescence , 2014, The Journal of Immunology.

[61]  E. Mekada,et al.  Requirement of CD9 on the egg plasma membrane for fertilization. , 2000, Science.

[62]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[63]  鈴木 真優美 Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation , 2009 .